BioCentury | Apr 7, 2014
Company News

Oculus, Ruthigen dermatology news

...products for surgical/advanced wound management and dermatology indications, including its Microcyn-based products for wound management. Microcyn...
BioCentury | Dec 16, 2013
Clinical News

Epicyn regulatory update

...evaluate Epicyn vs. current standard of care in Mexico. More Pharma has rights to Oculus' Microcyn-based...
...in Mexico, South and Central America, and the Caribbean (see BioCentury, Aug. 20, 2012). Oculus' Microcyn-based...
...and radiation dermatitis. Oculus markets the solution containing oxychlorine compounds in Europe and China as Dermacyn...
BioCentury | Dec 9, 2013
Clinical News

Microcyn Scar Management Hydrogel regulatory update

...FDA granted 510(k) clearance to Oculus' Microcyn Scar Management HydroGel to manage old and new hypertrophic...
...to Microcyn technology from Oculus under a 2011 deal (see BioCentury, Feb. 21, 2011). Oculus' Microcyn-based...
...China as Dermacyn to treat infected wounds. Oculus Innovative Sciences Inc. (NASDAQ:OCLS), Petaluma, Calif. Product: Microcyn...
BioCentury | Apr 8, 2013
Clinical News

Dermacyn Wound regulatory update

...the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) approved CE Mark reclassification of its Dermacyn wound...
...also classified as having an antimicrobial effect. Oculus markets the product in the U.S. as Microcyn...
...infected wounds. Oculus Innovative Sciences Inc. (NASDAQ:OCLS), Petaluma, Calif. Product: Dermacyn Wound ( Microcyn60 ) (Dermacyn, Microcyn...
BioCentury | Dec 3, 2012
Company News

Oculus infectious news

...that will hold the company's infectious disease assets, including a compound the uses the company's Microcyn...
BioCentury | Aug 20, 2012
Company News

Oculus, More Pharma Corp. sales and marketing update

...Oculus granted More Pharma an exclusive license to its Microcyn-based products in Mexico, South and Central...
...other regions covered under the deal. Oculus will remain responsible for manufacturing the products. Oculus' Microcyn-based...
BioCentury | Jul 2, 2012
Company News

AmDerma, Oculus deal

...Oculus granted AmDerma exclusive rights to develop and commercialize compounds using Oculus' Microcyn technology for dermatology...
BioCentury | Feb 27, 2012
Company News

Quinnova sales and marketing update

...Quinnova launched the Atrapro family of Microcyn-based products in the U.S. The launch includes Atrapro Antipruritic...
...various dermatoses and pH neutral Atrapro Dermal Spray for wound care. Quinnova has rights to Microcyn...
BioCentury | Aug 1, 2011
Company News

Ferndale Pharma Group, Oculus sales and marketing update

...Inc. subsidiary an exclusive, U.S. license to market its Microcyn-based wound care products, including its Microcyn...
...in January. Terms were not disclosed. Oculus reported $6 million in gross profit from its Microcyn...
BioCentury | Jul 4, 2011
Company News

AmDerma, Oculus deal

...AmDerma exercised an option to license Oculus' Microcyn technology for a yet to be determined formulation...
Items per page:
1 - 10 of 42